Advances in oligonucleotide drug delivery

TC Roberts, R Langer, MJA Wood - Nature reviews Drug discovery, 2020 - nature.com
Oligonucleotides can be used to modulate gene expression via a range of processes
including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation …

siRNA versus miRNA as therapeutics for gene silencing

JKW Lam, MYT Chow, Y Zhang, SWS Leung - Molecular Therapy-Nucleic …, 2015 - cell.com
Discovered a little over two decades ago, small interfering RNAs (siRNAs) and microRNAs
(miRNAs) are noncoding RNAs with important roles in gene regulation. They have recently …

RNA interference technology in crop protection against arthropod pests, pathogens and nematodes

M Zotti, EA Dos Santos, D Cagliari… - Pest management …, 2018 - Wiley Online Library
Scientists have made significant progress in understanding and unraveling several aspects
of double‐stranded RNA (dsRNA)‐mediated gene silencing during the last two decades …

[HTML][HTML] RNA-based technologies for insect control in plant production

S Liu, M Jaouannet, DMA Dempsey, J Imani… - Biotechnology …, 2020 - Elsevier
RNA interference (RNAi) is a biological process in which small RNA (sRNA) molecules
sequence-specifically silence gene expression at the transcriptional or post-transcriptional …

Off-target effects of RNAi correlate with the mismatch rate between dsRNA and non-target mRNA

J Chen, Y Peng, H Zhang, K Wang, C Zhao, G Zhu… - RNA biology, 2021 - Taylor & Francis
RNAi is a potent technique for the knockdown of target genes. However, its potential off-
target effects limit the widespread applications in both reverse genetic analysis and genetic …

Molecular mechanisms and potential therapeutical targets in Huntington's disease

C Zuccato, M Valenza, E Cattaneo - Physiological reviews, 2010 - journals.physiology.org
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG repeat
expansion in the gene encoding for huntingtin protein. A lot has been learned about this …

Antisense oligonucleotide therapies: the promise and the challenges from a toxicologic pathologist's perspective

KS Frazier - Toxicologic pathology, 2015 - journals.sagepub.com
Many antisense oligonucleotides (ASOs) from several classes of molecules are currently in
drug development. Despite over 20 years of pharmaceutical research, few ASOs have been …

The promises and pitfalls of RNA-interference-based therapeutics

D Castanotto, JJ Rossi - Nature, 2009 - nature.com
The discovery that gene expression can be controlled by the Watson–Crick base-pairing of
small RNAs with messenger RNAs containing complementary sequence—a process known …

Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity

AL Jackson, J Burchard, J Schelter, BN Chau, M Cleary… - Rna, 2006 - rnajournal.cshlp.org
Transfected siRNAs and miRNAs regulate numerous transcripts that have only limited
complementarity to the active strand of the RNA duplex. This process reflects natural target …

p53 activation by knockdown technologies

ME Robu, JD Larson, A Nasevicius, S Beiraghi… - PLoS …, 2007 - journals.plos.org
Morpholino phosphorodiamidate antisense oligonucleotides (MOs) and short interfering
RNAs (siRNAs) are commonly used platforms to study gene function by sequence-specific …